Karthik S. Suresh

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

G. Raghu, M. Scholand, J. Albayda, 2022, The Lancet. Respiratory medicine.